Global Breath Analyzers Market to Reach US$4.5 bn by 2019 owing to Rise in Number of Road Accidents

Transparency Market Research has published a new report on the global breath analyzers market. As per the report, the global breath analyzers market is expected to progress from US$402 mn in 2012 to US$4.5 bn by 2019. The report, titled ‘Breath Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ states that the global breath analyzers market is predicted to expand at a 41.30% CAGR during the period from 2013 to 2019 due to factors such as the rise in the incidence of diseases due to increasing drug abuse and increase in the number of road accidents because of excessive alcohol consumption.

Breath analyzers are medical equipment used for estimating the alcohol content of a person from an exhaled breath. These devices were first introduced in the market way back in the 1940’s for the detection of alcohol in the human body. Advancements in research and development have now advanced the use of breath analyzers or breath testing devices in the medical and healthcare sector for accurate diagnosis. Breath testing devices work on the simple principle of the measurement of gases in an exhaled breath at a low concentration. Owing to their non-invasive, accurate, and quick diagnosis, breath analyzers have gained tremendous importance in the recent past.

As per the World Health Organization (WHO), around 2.5 million people die every year due to excessive alcohol consumption. 20% of drivers injured due to road accidents are found to have consumed alcohol. The rise in the number of road accidents due to drinking and driving has created growth opportunities for the global breath analyzers market.

Government support and the introduction of new breath analyzer devices are expected to accelerate the growth of the global breath analyzer market in the years to come. Considering the many advantages of breath testing devices, leading players are focusing on developing breath analyzer devices for the detection of various diseases such as tuberculosis, asthma, and others.

The global breath analyzers market is segmented on the basis of application, geography, and technology. Based on geography, the global breath analyzer market is divided into North America, Asia Pacific, Europe, and Rest of the World. In 2012, in terms of revenue, North America dominated the global breath analyzer market due to the growing number of people addicted to or regularly using alcohol. Europe is predicted to be the second largest market in the global breath analyzers market in the years to come.

By application, the global breath analyzers market is classified into alcohol detection, drug abuse detection, H. pylori infection detection, asthma detection, and tuberculosis detection. At present, the global breath analyzers market is dominated by the tuberculosis detection segment.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=254

Some of the prominent players operating in the global breath analyzers market are Dragerwerk AG & Co, Intoximeters, Inc., Lifeloc Technologies, Inc., Alcohol Countermeasure Systems, Inc., and Quest Products. Based on technology, the global breath analyzers market is classified into infrared absorption fuel cell, and semiconductor sensor. Currently, the global breath analyzers market is led by the fuel cell technology.

Pre-Clinical Imaging Market - Current status and future trends

A new research study by Transparency Market Research (TMR) on the global pre-clinical imaging market states that the technical advancement in molecular imaging has boosted this market significantly in the recent times.

The research report, titled “Pre-Clinical Imaging Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018,” further states that the increasing application of multi-modality imaging techniques in the medical and healthcare sector has escalated the demand for pre-clinical imaging systems in the global arena, resulting in the market’s growth. However, the high cost associated with the implementation of imaging systems is restricting the worldwide market for pre-clinical imaging from registering a steady growth.

The imminent consolidation in the global pharmaceutical industry, coupled with the low rate of technology adoption, is also expected to hamper the rise of this market over the forecast period, states the report.

According to the research study, imaging systems and imaging reagents are the two major segments of the global market for pre-clinical imaging. The report further classifies the imaging systems segment into stand-alone imaging systems and multi-modal imaging systems. The multi-modal nuclear imaging devices and multi-modal optical imaging devices have been identified as the two prime sub-segments of the multi-modal imaging systems market.

The report also classifies the market for stand-alone imaging systems into micro-MRI, nuclear imaging, optical imaging, micro-CT, and micro-ultrasound.

The imaging reagents segment has been categorized into MRI contrasting reagents, nuclear imaging agents, optical imaging agents, CT contrast reagents, and ultrasound contrast reagents in the market study.

The worldwide market for preclinical imaging has also been assessed on the basis of its regional spread in this research report. North America, Europe, Asia Pacific, and the Rest of the World have been identified as the key regional markets for pre-clinical imaging in the global market.

Download PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1127

Among these, North America has acquired the leading position and has been closely followed by Europe. However, Asia Pacific is likely to emerge as the most lucrative market for pre-clinical imaging over the forecast period. The market in the Rest of the World is also expected to register substantial growth in the coming years, notes the study.

The research report presents an analysis of the competitive landscape of the worldwide preclinical imaging market by evaluating the company profile of the leading players operating in this market. As per the study, B.V., LI-COR Biosciences, Biospace Lab S.A., Aspect Imaging, MR Solutions Ltd., TriFoil Imaging, Mediso Medical Imaging Systems, Fujifilm VisualSonics Inc., Bruker Corp., and PerkinElmer Inc. are some of the major participants in the global pre-clinical imaging market.

Bone Grafts and Substitutes Market witness handsome growth in upcoming years

Bone grafts have been used for bone regeneration, structure restoration, and pain relief for decades. Conventionally, autografts were used for bone grafting, wherein patient’s own bone was used as a graft. Autologous bone grafts are considered a gold standard for bone transplant. However, usage of autologous bone grafts involves the risk of infection transfer; surgical procedures at both tissue harvesting and transplant sites which result in delayed wound healing and prolonged hospital stay. Hence, allografts were introduced in the market to overcome the disadvantages associated with autologous grafts. Allografts possess both osteoinductive and osteoconductive properties, and hence serve as a substitute for autografts. Ready availability of allografts in various shapes and sizes that can be processed in various forms such as chips and others as per requirement is likely to be one of the major factors fueling the growth of the allografts segment during the forecast period from 2015 to 2023. The allografts segment has been sub-segmented into demineralized bone matrix (DBM) and others. DBM is one of the most commonly utilized biomaterial with fewer side effects. There are a wide range of commercially available DBM products in the market. Moreover, continuous efforts to improve the mode of application of DBM is expected to boost the growth of the segment. Bone graft substitutes is the fastest growing segment of the global bone grafts and substitutes market. The bone graft substitutes segment comprises synthetic bone grafts, bone morphogenetic proteins (BMP), and others. Growth of the BMP segment is primarily driven by advantages over allograft tissues, which present a potential risk of disease transmission, morbidity, and availability issues. However, biocompatibility issues and high cost are some of the factors that restrain the growth of the BMP segment. Stryker Corporation and Medtronic plc dominate the BMP and other synthetic bone grafts segments.

Read Full Report: http://www.transparencymarketresearch.com/bone-grafts-substitutes-market.html

Bone grafts and substitutes are used in various application areas such as spinal fusion, foot and ankle, long bone, dental, joint reconstruction, and craniomaxillofacial procedures. Allografts are majorly used for the treatment of joint reconstruction, spinal, trauma, craniomaxillofacial, and dental procedures. Synthetic bone grafts are majorly used in long bone and spinal fusion procedures. The spinal fusion application segment dominated the global bone grafts and substitutes market in 2014 due to rising geriatric population and increasing global demand for minimally invasive surgeries. For instance, according to the American Academy of Orthopaedic Surgeons (AAOS), about 465,000 spinal surgeries were performed in the U.S. in 2011. Of all the spinal fusion surgeries performed, 46% were for lumbar fusion, 41% were for cervical fusion, and the remaining 13% were for thoracic or multi-level fusion procedures. Thus, rising incidence of spinal injuries is likely to drive the segment during the forecast period. On the other hand, rising preference for stem cell therapy and other growth factors such as platelet derived factors could hamper market growth during the forecast period.

North America accounted for the largest share of the global bone grafts and substitutes market in 2014, followed by Europe. The BGS market in North America is expected to witness a growth rate of 3.5% during the forecast period from 2015 to 2023. Factors such as strict compliance to governmental regulations, continuous technological advancements, and increased focus on patient safety and patient care have been attributed to the dominance of North America. In addition, rise in the number of road accidents and increasing awareness among people about various types of bone grafts and substitutes are the other factors propelling the growth of the market. The bone grafts and substitutes market in Asia Pacific is anticipated to expand at the highest CAGR during the forecast period from 2015 to 2023, followed by Latin America, due to evolving countries in terms of manufacturing capacity, technological development, and booming medical tourism industry in this region.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6200

Key players operating in the global bone grafts and substitutes market include AlloSource, Medtronic plc, Stryker Corporation, Baxter International, DePuy Synthes, Nuvasive, Inc., Wright Medical Group, Zimmer, Inc., and Orthofix Holdings, Inc.

3D Printing in Medical Applications Market Segment Forecast up to 2019

A new Transparency Market Research report states that the global 3D printing in medical applications market stood at US$354.5 mn in 2012 and is predicted to reach US$965.5 mn by 2019. It is predicted to expand at an extraordinary CAGR of 15.40% from 2013 to 2019. The title of the report is “3D Printing in Medical Applications Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.”

3D printing or three-dimensional printing is a manufacturing method wherein objects are manufactured by depositing or fusing materials such as metals, plastics, powders, ceramics, living cells, and liquids in layers for producing a 3D object. The use of 3D printing in medical applications is swiftly rising. The medical utilization of 3D printing, both potential and actual, can be segmented into several categories such as the creation of customized implants, prosthetics, and anatomical models, and tissue and organ fabrication, among others.

As per the report, the rising funding by private and government agencies globally and the increasing count of medical applications will propel the growth of the market. In addition, the increasing technological advancements for widening the scope of medical applications are also boosting the growth of the market. Furthermore, the increasing trend of customization of 3D printed medical products and the reduced costs and time of medical procedures due to usage of 3D printing are also augmenting the growth of the market. On the other hand, the absence of trained professionals is a key factor restraining the growth of the market.

In terms of application, the market for 3D printing in medical applications is segmented into surgical guides, surgical instrument, implants, and bioengineering. The segments of surgical guides and implants are further segmented into dental, orthopedic, and cranio-maxillofacial. Amongst these, the segment of implants is predicted to expand at the highest CAGR of 15% between 2013 and 2019.

By technology, the report segments the market into electron bean melting (EBM), droplet deposition manufacturing, and stereolithography. The segment of EBM is further segmented into photopolymerization and laser beam melting (LBM). The segment of droplet deposition manufacturing is further segmented into fused deposition modeling, inkjet printing, and multiphase jet solidification. On the other hand, the segment of stereolithography is further segmented into digital light processing and two-photon polymerization. Amongst these, the segments of LBM and photopolymerization led the market in 2013 and are predicted to rise at the greatest growth rate in the forecast horizon. In terms of raw material, the report segments the market into polymers, metals, biological cells, and ceramics.

On the basis of geography, the report segments the market into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, North America led the market in 2012. On the other hand, Europe is expected to rise at the greatest CAGR from 2013 to 2019. This is owing to the rising funding by governments and the increasing number of mergers and acquisitions between companies for technological developments within Europe.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1522

As stated in the report, the chief players dominant in the market for 3D printing in medical applications are EnvisionTEC GmbH, 3D System, Stratasys Inc., and Materialise NV, among others.

Interventional Cardiology Devices Market: Challenges and Opportunities

Coronary artery bypass surgery (CABG) was discovered around 50 years ago as a surgical procedure of treating coronary complications. Since then, CABG has remained one of the most commonly administered surgical procedures to treat coronary complexities such as ischemia and multi-vessel coronary artery disease (CAD). However, with technological advances in the healthcare sector, demand for CABG has registered a continuous decrease. The emergence of technologies such as interventional cardiology has ushered in a new era of minimally invasive coronary surgeries.

Interventional Cardiology Devices Market to Reach US$11.2 billion in 2020

Interventional cardiology is a catheter-based minimally invasive surgery that offers a myriad advantages such as minimal incision, reduced post-surgical complications, lesser expenditure, and shorter hospital stay and shorter recovery time. Owing to such advantages, the demand for interventional cardiology devices has exhibited a steady rise. A market study published by Transparency Market Research states that the global interventional cardiology devices market will demonstrate a 2.9% CAGR between 2014 and 2020. The market is likely to reach US$11.2 billion in 2020 as against its market valuation of US$8.7billion in 2013.

High Incidence of Coronary Artery Diseases (CAD) to Boost Global Market

Expanding global geriatric population, coupled with rising incidence of coronary artery diseases, are the primary factors driving the global interventional cardiology devices market. Adherence to hazardous habits and lifestyle patterns such as smoking, unhealthy diet, and hectic schedules has led to rise in obesity and dietary irregularities, the two most common causes of coronary artery diseases.Studies have revealed that in Europe alone, CAD accounts for 1.9 million deaths every year. It has been observed that 1 individual among 5 in Europe dies as a result of coronary artery diseases. The ailment is also one of the most common causes of premature deaths. Studies indicate that the high prevalence of the disease will boost the demand for PCIs or percutaneous coronary interventions. This will aid the interventional cardiology devices market to gain momentum

Demand for Bioabsorbable Stents Likely to Increase

Among the most commonly used interventional cardiology devices, including catheters, stents, PTCA guidewires, PTCA balloons, and others, stents accounted for the largest share in the market in 2013. The stents market is sub-categorized into drug eluting stents, bioabsorbable vascular stents, and bare metal stents. Of these, drug eluting stents (DES) enjoyed dominance in the market in 2013. The incumbent trends indicate continuous growth in demand for drug eluting stents in the forthcoming years. High rate of recovery observed in patients using drug eluting stents compared to metal stents has significantly contributed to the high demand for DES. However, in the next couple of years, the DES segment is likely to lose its market share to bioabsorbable vascular stents (BVS). Complete absorption of stent material into the bloodstream is possible in BVS, which significantly reduces the chances of late-stent restenosis. Owing to such factors, the BVS segment in the interventional cardiology devices market is likely to register the fastest growth in the near future.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=853

North America Leads the Global Interventional Cardiology Devices Market

The global interventional cardiology devices market can be classified into North America, Latin America, Asia Pacific, Europe, Middle East and North America, and Rest of the World. North America led the global interventional cardiology devices market. Europe and Asia Pacific were the second and third largest interventional cardiology devices market respectively. The market opportunities in Asia Pacific is largely untapped, this along with rising healthcare expenditure will help the interventional cardiology market in the region gain tremendous momentum.

Some of the leading players in the market include Boston Scientific Corporation, Abbott Laboratories, Inc., B. Braun Melsungen AG, Abbott Laboratories, Inc., Medtronic, plc, Boston Scientific Corporation, Smiths Medical, Cordis Corporation, St. Jude Medical, Inc., Cook Medical, and Terumo Medical Corporation. Key players in this market compete against each other to obtain enhanced market share and sustain the same in the near future.

Negative Pressure Wound Therapy Market : New Insights for the Healthcare

Negative Pressure Wound Therapy (NPWT) is an advance wound care therapy that applies sub-atmospheric or negative pressure to a wound in a closed drainage system. NPWT devices uses an electrical as well as a mechanical suction pump to continuously or intermittently convey negative pressure through connecting tubes to specially designed wound dressings kits that include resilient foam and gauze dressings and thereby promote faster wound healing. NPWT promotes wound healing by reducing edema, by stimulating granulation tissue and cell proliferation as well as by increasing blood circulation. NPWT systems can be used for the treatment of surgical wounds, traumatic wounds, chronic wounds such as diabetic foot ulcers and venous stasis ulcers as well as pressure sores. NPWT systems are segmented on the basis of type of devices into conventional NPWT systems and single use NPWT systems. Further, conventional NPWT systems are bifurcated on the basis of disposables into canisters, pumps and dressing kits. In addition, NPWT systems can also be used for the treatment of injuries associated with burns and meshed skin grafts.

The primary factors contributing to the growth of this market are globally increasing geriatric population; as well as increasing incidence and prevalence rate of chronic diseases such as cancer and diabetes leading to rise in chronic wounds. Moreover, high awareness about advance wound care devices and patient preference for the treatment with minimum side-effects are also driving the growth of this market.

In products segment, conventional NPWT systems account for the largest market segment while, single use NPWT systems market segment is growing with highest CAGR of approximately17 % during forecast period from 2014 to 2020. NPWT market is witnessing a paradigm shift from usage of conventional NPWT systems towards single use NPWT systems owing to preference of patients towards portable and cost effective wound care devices. This shift in preference is mainly related to convenience of patients since they try to avoid bulky and expensive conventional NPWT systems compared to portable single use NPWT systems.

Rising Investments in Emerging Markets Fueling Growth

North America is the most prominent market for negative pressure wound therapy at the moment, driven by increasing levels of patient awareness, rapidly aging population, growing prevalence of chronic diseases, high percentage of diabetic population, and favorable and supportive reimbursement policies. Europe is also a key market for negative pressure wound therapy, propelled by increased prevalence of chronic wounds and high incidence of transit accidents.

Download PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1718

However, emerging economies have been identified as the most lucrative market for negative pressure wound therapy, thanks to rising investments in healthcare and development of novel technologies. Asia Pacific is anticipated to witness the highest growth among other regional markets and this development can be attributed to supportive government policies, strong economic development, increased demand for advanced wound care products, and rise in healthcare expenditure.

On the down side, high cost of advanced wound care devices, unfavorable reimbursement policies in certain countries, and reluctance in adopting technologically advanced devices in some regions are anticipated to restrict the growth of the market.

Realizing the potential of negative pressure wound therapy, the competition within the global market has increased, making room for advanced and more convenient solutions. Some of the leading vendors engaged in the global negative pressure wound therapy market are Devon Medical, Inc., Medela AG, Genadyne Biotechnologies, Inc., ConvaTec, Inc., Kinetic Concepts, Inc., ArjoHuntleigh International AB, Prospera Technologies LLC, Talley Group Limited, Smith & Nephew PLC, and Mölnlycke Health Care AB.

Laser Capture Microdissection Market Responds to Impressive Progress in Medicine and Healthcare

Human tissues are composed of complex mixtures of different cell types and their biological analysis requires the procurement of pure samples of the cells of interest. Number of approaches have been used in attempts to overcome this difficulty. Laser capture microdissection (LCM) is anautomated sample preparation technology used to isolate and harvest the specific cells of interest from tissue, or organisms by direct microscopic visualization. The technique also called as laser microdissection (LMD), or laser assisted microdissection (LAM or LMD). This technology facilitates the formulation of homogenous isolates of clear cells through which DNA/RNA and various proteins can be achieved for further performingmass spectrophotometry, western blot analyses, polymerase chain reaction (PCR), and quantitative PCR. Certain benefits, such as contamination free and contact free technique, allows more efficient and accurate results, and preservance of cells with an original morphology are expected to provide good growth in the global market. Laser microdissection is now used in a large number of research fields, e.g. cancer research,neurology, forensics or climate research,and plant analysis. The method is for the time being also applied for manipulation of cell cultures or for microengraving of coverslips.A diversity of downstream applications of laser capture microdissection technique are exist includes DNA genotyping and loss-of-heterozygosity (LOH) analysis, RNA transcript profiling, proteomics discovery, cDNA library generation, and signal-pathway profiling.

Global laser capture microdissection market is segmented by product type, system type, application, and end users.By product, the global market further segmented intoinstruments, reagents and media, assay kits, consumables, and software and services.The system types segmented into infrared LCM, ultraviolet LCM,immunofluorescence LCM, and ultraviolet and infrared LCM. By considering application, LCM market segmented into diagnostics, research and development, and other applications.Whereas, by end users market might be segmented into academic and government research hospitals, institutes, pharmaceutical companies, CROs and biotechnology companies. Geographically, laser capture microdissection market can be categorized into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. By product type, instrument segment is expected to account largest share of the global LCM market during forecast period. However, consumables segment observed highest growth rate. Geographically, North America accounted largest share of the market due to availability of skilled personnel to handle LCM technology. However, Asian market is witnessing strongest growth during the forecast period due to expansion of LCM companies and R & D spending. Overall growth of the market is attributed due to strong trend in CROs and pharmaceutical companies. Hence, by end users pharmaceutical companies’ accounted largest share in global laser capture microdissection market 2014.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7682

Increasing healthcare expenditure, growing R & D funding, and technical advantages are primary growth drivers of this market. The high-growth potential in emerging markets provide new growth opportunities and technological advancements provide new growth trends to players in the laser capture microdissection market. However,high manufacturing and maintenance cost of equipment and accessories, and lack of skilled personnel are major restraint of the Laser capture microdissection market.

Some of the major players in the laser capture microdissection market include Thermo Fisher Scientific, Inc. (U.S.), Molecular, Machines & Industries (Germany),Danaher Corporation (U.S.), Carl Zeiss AG (Germany), INDIVUMED GmbH (Germany), DeNova Sciences Pte. Ltd. (Singapore), Theranostics Health Inc. (U.S.), Ocimum Biosolutions LLC (U.S.), 3DHISTECH Ltd. (Hungary), and AvanSci Bio LLC (U.S.).